Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | BRD2 | P25440 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PARL | Q9H300 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13158271 | 0.90 | GAA (0.44) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL13158284 | 0.82 | PARL (0.41) | PARL | |
| SCHEMBL28339322 | 0.71 | GAA (0.48) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL10122963 | 0.69 | GAA (0.47) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL3779668 | 0.67 | GAA (0.46) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL14635436 | 0.67 | GAA (0.50) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL27210198 | 0.67 | GAA (0.46) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL13158265 | 0.66 | GAA (0.44) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL29235813 | 0.66 | GAA (0.44) | GAABRD4BRD2MEN1KMT2A | |
| SCHEMBL29905661 | 0.64 | POLB (0.46) | GAABRD4BRD2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255388-A1 | TRIARYLAMINE DERIVATIVE | FUJIFILM CORPORATION (JP) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255388-A1 | TRIARYLAMINE DERIVATIVE | GPR35, NR1I2, GPR55 | GAA 4243/4885BRD4 512/4885BRD2 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.